BE2022C521I2 - - Google Patents
Download PDFInfo
- Publication number
- BE2022C521I2 BE2022C521I2 BE2022C521C BE2022C521C BE2022C521I2 BE 2022C521 I2 BE2022C521 I2 BE 2022C521I2 BE 2022C521 C BE2022C521 C BE 2022C521C BE 2022C521 C BE2022C521 C BE 2022C521C BE 2022C521 I2 BE2022C521 I2 BE 2022C521I2
- Authority
- BE
- Belgium
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48018203P | 2003-06-20 | 2003-06-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE2022C521I2 true BE2022C521I2 (enExample) | 2024-04-23 |
Family
ID=33539267
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE2022C521C BE2022C521I2 (enExample) | 2003-06-20 | 2022-05-30 |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1638938B1 (enExample) |
| JP (2) | JP4884216B2 (enExample) |
| AU (1) | AU2004249250C1 (enExample) |
| BE (1) | BE2022C521I2 (enExample) |
| CA (1) | CA2529761C (enExample) |
| DK (1) | DK1638938T3 (enExample) |
| ES (1) | ES2632313T3 (enExample) |
| FR (1) | FR22C1022I1 (enExample) |
| NL (1) | NL301177I2 (enExample) |
| PL (1) | PL1638938T3 (enExample) |
| WO (1) | WO2004112718A2 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004249250C1 (en) * | 2003-06-20 | 2012-04-12 | Siga Technologies, Inc. | Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| US7737168B2 (en) * | 2003-06-20 | 2010-06-15 | Siga Technologies, Inc. | Compounds, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| AU2012268859B2 (en) * | 2003-06-20 | 2016-05-05 | Siga Technologies, Inc. | Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| US8530509B2 (en) | 2003-06-20 | 2013-09-10 | Siga Technologies, Inc. | Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| JP5137574B2 (ja) * | 2004-08-30 | 2013-02-06 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | １１−ベータヒドロキシステロイドヒドロゲナーゼ阻害剤としての三環式ラクタム誘導体 |
| US7994221B2 (en) | 2004-12-06 | 2011-08-09 | Siga Technologies, Inc. | Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses |
| US8410149B2 (en) | 2004-12-06 | 2013-04-02 | Siga Technologies Inc. | Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses |
| JP5285276B2 (ja) | 2004-12-06 | 2013-09-11 | シガ テクノロジーズ，インコーポレーテッド | アレナウイルスに関連した感染をはじめとする出血熱ウイルスを処置するための、スルホニルセミカルバジド、セミカルバジドおよび尿素、その医薬組成物および方法 |
| EP1865967A4 (en) * | 2005-04-08 | 2011-02-09 | Chimerix Inc | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS AND OTHER DISEASES |
| JP2008535862A (ja) * | 2005-04-08 | 2008-09-04 | キメリクス，インコーポレイテッド | ポックスウイルス感染の治療のための化合物、組成物および方法 |
| JP2010535705A (ja) * | 2007-04-23 | 2010-11-25 | シガ テクノロジーズ，インコーポレーテッド | オルソポックスウイルス感染及び関連疾患の治療及び予防のための化学物質、組成物、及び方法 |
| AU2009206673B2 (en) | 2008-01-25 | 2015-04-23 | Chimerix, Inc. | Methods of treating viral infections |
| US8614200B2 (en) | 2009-07-21 | 2013-12-24 | Chimerix, Inc. | Compounds, compositions and methods for treating ocular conditions |
| RU2412167C1 (ru) * | 2009-12-02 | 2011-02-20 | Федеральное государственное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФГУН ГНЦ ВБ "Вектор" Роспотребнадзора) | {3,5-диоксо-4-азатетрацикло[5.3.2.02,6.08,10]додец-11-ен-4-ил}тиомочевина, обладающая противовирусной активностью в отношении ортопоксвирусов |
| RU2412168C1 (ru) * | 2009-12-02 | 2011-02-20 | Федеральное государственное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФГУН ГНЦ ВБ "Вектор" Роспотребнадзора) | Гидрат n-{3,5-диоксо-4-азатетрацикло[5.3.2.02,6.08,10]додец-11-ен-4-ил}-2-гидроксибензамида, обладающий противовирусной активностью в отношении ортопоксвирусов |
| EP3216789A1 (en) | 2010-02-12 | 2017-09-13 | Chimerix, Inc. | Methods of treating viral infection |
| AU2011232551B2 (en) | 2010-03-23 | 2014-11-13 | Siga Technologies, Inc | Polymorphic forms ST-246 and methods of preparation |
| CA2797601A1 (en) | 2010-04-26 | 2011-11-10 | Chimerix, Inc. | Methods of treating retroviral infections and related dosage regimes |
| CN106074370A (zh) | 2010-08-05 | 2016-11-09 | 西佳科技股份有限公司 | St‑246液体配制物以及方法 |
| CN101906064A (zh) * | 2010-08-09 | 2010-12-08 | 中国人民解放军军事医学科学院微生物流行病研究所 | St-246的立体异构体的制备方法 |
| RU2440983C1 (ru) * | 2010-09-28 | 2012-01-27 | Новосибирский институт органической химии им. Н.Н. Ворожцова Сибирского отделения Российской академии наук (НИОХ СО РАН) | Метил, хлор и нитропроизводные n-{3, 5-диоксо-4-азатетрацикло[5.3.2.02,6.08,10]додец-11-ен-4-ил}-2-гидроксибензамида-противовирусные препараты, ингибирующие репликацию различных видов ортопоксвирусов |
| CN111393354B (zh) | 2012-08-16 | 2023-06-20 | 西佳技术公司 | 制备特考韦瑞的方法 |
| CA3128535C (en) | 2013-07-19 | 2024-10-15 | Siga Technologies, Inc. | PREPARATION OF AMORPHIC TECOVIRIMAT |
| IL315763A (en) * | 2022-03-27 | 2024-11-01 | Univ Texas | Small molecule inhibitors of lanostral synthase |
| CN116730995B (zh) * | 2022-08-12 | 2024-06-25 | 深圳微芯生物科技股份有限公司 | 一类酰肼类化合物、其制备方法及其应用 |
| CN116003309B (zh) * | 2022-08-12 | 2025-03-04 | 深圳微芯生物科技股份有限公司 | 一类酰肼类化合物、其制备方法及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2906755A (en) * | 1956-11-16 | 1959-09-29 | Schenley Ind Inc | N-acyl derivatives of alpha-pyridine carboxylic acid hydrazide |
| US4061763A (en) * | 1975-05-09 | 1977-12-06 | Merck & Co., Inc. | Tricyclicdicarboximides |
| JPS5247844A (en) * | 1975-10-15 | 1977-04-16 | Ube Ind Ltd | Elastomer compositions |
| JPS6483065A (en) * | 1987-09-25 | 1989-03-28 | Hitachi Chemical Co Ltd | Endo-cis-3,6-cyclopropylene-tetra(or hexa)hydrophthalic acid imide derivative and antiarhythmic agent |
| US5068356A (en) * | 1990-02-20 | 1991-11-26 | Atochem North America, Inc. | Hindered phenolic n-(amido)imides |
| US6596771B2 (en) | 2001-01-12 | 2003-07-22 | Schering Corporation | Drugs for treating viral infections |
| US6433016B1 (en) * | 2001-01-12 | 2002-08-13 | Vassil Stefanov Georgiev | Drugs for treating viral infections |
| US20040087548A1 (en) * | 2001-02-27 | 2004-05-06 | Salvati Mark E. | Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| AU2004249250C1 (en) * | 2003-06-20 | 2012-04-12 | Siga Technologies, Inc. | Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
-
2004
- 2004-06-18 AU AU2004249250A patent/AU2004249250C1/en not_active Expired
- 2004-06-18 JP JP2006517409A patent/JP4884216B2/ja not_active Expired - Lifetime
- 2004-06-18 EP EP04776765.2A patent/EP1638938B1/en not_active Expired - Lifetime
- 2004-06-18 DK DK04776765.2T patent/DK1638938T3/en active
- 2004-06-18 CA CA2529761A patent/CA2529761C/en not_active Expired - Lifetime
- 2004-06-18 ES ES04776765.2T patent/ES2632313T3/es not_active Expired - Lifetime
- 2004-06-18 PL PL04776765T patent/PL1638938T3/pl unknown
- 2004-06-18 WO PCT/US2004/019552 patent/WO2004112718A2/en not_active Ceased
-
2011
- 2011-08-18 JP JP2011179109A patent/JP5657489B2/ja not_active Expired - Lifetime
-
2022
- 2022-05-30 BE BE2022C521C patent/BE2022C521I2/nl unknown
- 2022-06-02 NL NL301177C patent/NL301177I2/nl unknown
- 2022-06-02 FR FR22C1022C patent/FR22C1022I1/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP5657489B2 (ja) | 2015-01-21 |
| JP4884216B2 (ja) | 2012-02-29 |
| JP2007521273A (ja) | 2007-08-02 |
| AU2004249250B2 (en) | 2011-09-01 |
| ES2632313T3 (es) | 2017-09-12 |
| NL301177I1 (nl) | 2022-06-08 |
| AU2004249250A1 (en) | 2004-12-29 |
| FR22C1022I1 (fr) | 2022-07-22 |
| EP1638938A2 (en) | 2006-03-29 |
| AU2004249250C1 (en) | 2012-04-12 |
| DK1638938T3 (en) | 2017-07-31 |
| EP1638938A4 (en) | 2008-09-17 |
| NL301177I2 (nl) | 2022-08-23 |
| WO2004112718A2 (en) | 2004-12-29 |
| PL1638938T3 (pl) | 2017-10-31 |
| EP1638938B1 (en) | 2017-04-12 |
| JP2011252019A (ja) | 2011-12-15 |
| CA2529761C (en) | 2013-08-13 |
| CA2529761A1 (en) | 2004-12-29 |
| WO2004112718A3 (en) | 2005-04-07 |